SG10201406288SA - Multimeric forms of antimicrobial peptides - Google Patents

Multimeric forms of antimicrobial peptides

Info

Publication number
SG10201406288SA
SG10201406288SA SG10201406288SA SG10201406288SA SG10201406288SA SG 10201406288S A SG10201406288S A SG 10201406288SA SG 10201406288S A SG10201406288S A SG 10201406288SA SG 10201406288S A SG10201406288S A SG 10201406288SA SG 10201406288S A SG10201406288S A SG 10201406288SA
Authority
SG
Singapore
Prior art keywords
peptides
multimeric forms
antimicrobial
defensin
antimicrobial peptides
Prior art date
Application number
SG10201406288SA
Other languages
English (en)
Inventor
Roger W Beuerman
Shouping Liu
Jing Li
Lei Zhou
Chandra Shekhar Verma
Donald Tan
Original Assignee
Singapore Health Serv Pte Ltd
Agency Science Tech & Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Health Serv Pte Ltd, Agency Science Tech & Res filed Critical Singapore Health Serv Pte Ltd
Publication of SG10201406288SA publication Critical patent/SG10201406288SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Eyeglasses (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201406288SA 2008-04-21 2009-04-21 Multimeric forms of antimicrobial peptides SG10201406288SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4658408P 2008-04-21 2008-04-21

Publications (1)

Publication Number Publication Date
SG10201406288SA true SG10201406288SA (en) 2014-12-30

Family

ID=41217076

Family Applications (1)

Application Number Title Priority Date Filing Date
SG10201406288SA SG10201406288SA (en) 2008-04-21 2009-04-21 Multimeric forms of antimicrobial peptides

Country Status (8)

Country Link
US (1) US8809262B2 (fr)
EP (2) EP2279202B1 (fr)
JP (2) JP5753077B2 (fr)
AU (1) AU2009238701B2 (fr)
BR (1) BRPI0910473A2 (fr)
SG (1) SG10201406288SA (fr)
WO (1) WO2009131548A1 (fr)
ZA (1) ZA201007509B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2010561A4 (fr) * 2006-04-27 2010-03-24 Singapore Health Services Pte Peptides antimicrobiens
US20110311601A1 (en) * 2010-06-22 2011-12-22 Michael Kleine Antimicrobial medical devices
CN107652364A (zh) * 2011-04-02 2018-02-02 新加坡保健服务集团 抗菌肽的多聚体形式
JP2015529220A (ja) * 2012-09-07 2015-10-05 エイジェンシー フォー サイエンス， テクノロジー アンド リサーチ 新規抗菌薬群としての四分岐ペプチドおよびその類似体ならびにそれらの製造
SG11201501646PA (en) * 2012-09-07 2015-04-29 Agency Science Tech & Res Peptides and their uses
JP6362878B2 (ja) * 2013-03-12 2018-07-25 国立研究開発法人農業・食品産業技術総合研究機構 改変ペプチド繰り返しペプチドを含む融合タンパク質および該融合タンパク質を含むシルク繊維
WO2015138494A1 (fr) 2014-03-10 2015-09-17 Georges Belfort Peptides anti-microbiens et procédé de conception de nouveaux peptides anti-microbiens
WO2016081594A1 (fr) * 2014-11-19 2016-05-26 The General Hospital Corporation Système et procédé pour protocole photodynamique
WO2016191790A1 (fr) * 2015-05-29 2016-12-08 Hexima Limited Procédé de traitement in vivo
US20180371018A1 (en) * 2015-12-14 2018-12-27 Su HAN Polypeptide compound, preparation method therefor and use thereof
US20220133699A1 (en) 2019-02-14 2022-05-05 Singapore Eye Research Institute Antibacterial Compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5057520A (en) * 1989-03-24 1991-10-15 Abbott Laboratories 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5919761A (en) * 1992-08-14 1999-07-06 The Board Of Regents Of The University Of Michigan Peptides for heparin and low molecular weight heparin anticoagulation reversal
US8172395B2 (en) 2002-12-03 2012-05-08 Novartis Ag Medical devices having antimicrobial coatings thereon
GB0514482D0 (en) * 2005-07-14 2005-08-17 Ares Trading Sa Protein
WO2007025178A2 (fr) * 2005-08-26 2007-03-01 New York University Compositions multimeres polyvalentes contenant des polypeptides actifs, compositions pharmaceutiques et procedes utilisant celles-ci
US7531505B2 (en) * 2006-01-11 2009-05-12 Affinergy, Inc. Compositions and methods for promoting attachment of cells of endothelial cell lineage to medical devices
EP2010561A4 (fr) * 2006-04-27 2010-03-24 Singapore Health Services Pte Peptides antimicrobiens

Also Published As

Publication number Publication date
JP2011521902A (ja) 2011-07-28
EP2853539B1 (fr) 2018-10-10
EP2279202B1 (fr) 2015-08-12
BRPI0910473A2 (pt) 2019-09-24
EP2279202A4 (fr) 2011-08-31
ZA201007509B (en) 2013-06-26
WO2009131548A8 (fr) 2010-11-25
EP2853539A1 (fr) 2015-04-01
AU2009238701B2 (en) 2013-06-20
AU2009238701A1 (en) 2009-10-29
US8809262B2 (en) 2014-08-19
WO2009131548A1 (fr) 2009-10-29
US20110039760A1 (en) 2011-02-17
JP2015145373A (ja) 2015-08-13
JP5753077B2 (ja) 2015-07-22
EP2279202A1 (fr) 2011-02-02

Similar Documents

Publication Publication Date Title
SG10201406288SA (en) Multimeric forms of antimicrobial peptides
EP2494059A4 (fr) Utilisation de méthysulfonylméthane (msm) à des fins de modulation de l'activité microbienne
CA2747703C (fr) Compositions et methodes de traitement ou de prevention d'infections par e. coli
TW201712023A (en) Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups
GEP20156309B (en) Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
MY148844A (en) Fumarate salt of (alpha s, beta r)-6- bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
MX2013000821A (es) Nuevas aminopirazoloquinazolinas.
MX2012002366A (es) Agonistas novedosos de receptores beta 3 andrenergicos derivados de pirrolidina.
UA114528C2 (uk) Комбінації активних сполук, що містять карбоксамідні похідні та засіб біологічної боротьби
MX2009007345A (es) Compuestos con (fenil sustituido), con restos de propenal, sus derivados, actividad biologica y uso del mismo.
MX2009008542A (es) Agentes de suministro de acido fenilalquilcarboxilico.
EP2588491A4 (fr) Nouveau peptide et son utilisation
WO2014060610A3 (fr) Peptides antimicrobiens
MX2014001599A (es) 3,4-dihidro-1h-[1,8]naftiridinosas sustituidas con piperidinilo antibacterianas.
GB0404374D0 (en) Treatment of bacterial infections
MX2012000136A (es) Composiciones que comprenden finafloxacina y metodos para tratar infecciones oftalmicas, oticas, o nasales.
MX341220B (es) Polisacarido de semillas de tamarindo para usarse en el tratamiento de infecciones microbianas.
ATE495164T1 (de) Thiadiazolderivate zur behandlung neurodegenerativer krankheiten
AU2011279845A8 (en) Novel pyrrolidine derived beta 3 adrenergic receptor agonists
MY152685A (en) Imidazopyridazines as par1 inhibitors, production thereof, and use thereof as medicaments
CL2013000331A1 (es) Compuestos derivados de triazina-1,2 diazol condezada o de triazina-1,2,4-triazol condensada; proceso para preparar estos compuestos; composicion farmaceutica; proceso para preparar esta composicion farmaceutica; y su uso para el tratamiento de una infeccion bacteriana tal como una infeccion por la bacteria clostridium.
MX360559B (es) Péptidos antimicrobianos, composiciones que los comprende y usos.
WO2008061112A3 (fr) Composés pharmaceutiques comme inhibiteurs de la prolifération cellulaire et leur utilisation
MX2023005893A (es) Composicion farmaceutica para prevenir o tratar una herida o cicatriz, que comprende benzbromarona.
MX2012004282A (es) Composiciones farmaceuticas.